Latest filing published 05 Mar 2017 for Veritas Pharma Inc., €144k.
David Alexander discloses dealings in Veritas Pharma Inc. to SEDI. Between 7 January 2016 and 28 February 2017, the trades on record add up to 4 filings.
Both buying and selling appear: 1 purchase worth €103k, against 1 sale worth €144k. Sales outweigh purchases by €41k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2017 to date brings 1 purchase and 1 sale.
On 5 March 2017 came the latest disclosure, an open-market sale for €144k in Veritas Pharma Inc. The most recent open-market purchase was published on 5 March 2017, 3,523 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 14 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations